Cheng Fu
Shenyang, 110042, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Retraction Notice to: circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells.
Journal: Molecular therapy. Nucleic acids
Published: May 24, 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 26, 2023
Tislelizumab, a novel PD-1 monoclonal antibody in urothelial cancer: A real-world study.
Journal: Actas urologicas espanolas
Published: September 09, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 03, 2023
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial.
Journal: International journal of cancer
Published: November 09, 2022
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.
Journal: Chinese medical journal
Published: September 27, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 05, 2022
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Journal: The New England journal of medicine
Published: February 18, 2022
Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Journal: Cancer gene therapy
Published: January 28, 2022
Detecting urine metabolites of bladder cancer by surface-enhanced Raman spectroscopy.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: May 27, 2020
circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells.
circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells.
Journal: Molecular therapy. Nucleic acids
Published: April 10, 2020
Last Updated: 09/26/2026